Q

Qingdao Baheal Medical Inc
SZSE:301015

Watchlist Manager
Qingdao Baheal Medical Inc
SZSE:301015
Watchlist
Price: 27.18 CNY -1.52% Market Closed
Market Cap: 14.3B CNY
Have any thoughts about
Qingdao Baheal Medical Inc?
Write Note

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Qingdao Baheal Medical Inc

Revenue
7.5B CNY
Cost of Revenue
-5.2B CNY
Gross Profit
2.3B CNY
Operating Expenses
-1.3B CNY
Operating Income
973m CNY
Other Expenses
-250.5m CNY
Net Income
722.5m CNY

Margins Comparison
Qingdao Baheal Medical Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CN
Qingdao Baheal Medical Inc
SZSE:301015
14.3B CNY
30%
13%
10%
US
Mckesson Corp
NYSE:MCK
77.5B USD
4%
1%
1%
US
Amerisourcebergen Corp
LSE:0HF3
48.9B USD
3%
1%
1%
US
Cencora Inc
NYSE:COR
48.7B USD
3%
1%
1%
US
Cardinal Health Inc
NYSE:CAH
30.4B USD
3%
1%
1%
US
Henry Schein Inc
NASDAQ:HSIC
9.3B USD
32%
5%
3%
CN
Huadong Medicine Co Ltd
SZSE:000963
65B CNY
32%
10%
8%
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
30%
9%
7%
CN
Sinopharm Group Co Ltd
HKEX:1099
65.4B HKD
8%
4%
1%
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
60.9B CNY
11%
3%
1%
IT
Amplifon SpA
MIL:AMP
5.5B EUR
24%
12%
7%
Country CN
Market Cap 14.3B CNY
Gross Margin
30%
Operating Margin
13%
Net Margin
10%
Country US
Market Cap 77.5B USD
Gross Margin
4%
Operating Margin
1%
Net Margin
1%
Country US
Market Cap 48.9B USD
Gross Margin
3%
Operating Margin
1%
Net Margin
1%
Country US
Market Cap 48.7B USD
Gross Margin
3%
Operating Margin
1%
Net Margin
1%
Country US
Market Cap 30.4B USD
Gross Margin
3%
Operating Margin
1%
Net Margin
1%
Country US
Market Cap 9.3B USD
Gross Margin
32%
Operating Margin
5%
Net Margin
3%
Country CN
Market Cap 65B CNY
Gross Margin
32%
Operating Margin
10%
Net Margin
8%
Country KR
Market Cap 12.2T KRW
Gross Margin
30%
Operating Margin
9%
Net Margin
7%
Country CN
Market Cap 65.4B HKD
Gross Margin
8%
Operating Margin
4%
Net Margin
1%
Country CN
Market Cap 60.9B CNY
Gross Margin
11%
Operating Margin
3%
Net Margin
1%
Country IT
Market Cap 5.5B EUR
Gross Margin
24%
Operating Margin
12%
Net Margin
7%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Qingdao Baheal Medical Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CN
Qingdao Baheal Medical Inc
SZSE:301015
14.3B CNY
29%
13%
29%
20%
US
Mckesson Corp
NYSE:MCK
77.5B USD
-105%
4%
27%
18%
US
Amerisourcebergen Corp
LSE:0HF3
48.9B USD
258%
2%
23%
17%
US
Cencora Inc
NYSE:COR
48.7B USD
258%
2%
23%
17%
US
Cardinal Health Inc
NYSE:CAH
30.4B USD
-37%
3%
26%
17%
US
Henry Schein Inc
NASDAQ:HSIC
9.3B USD
9%
3%
8%
5%
CN
Huadong Medicine Co Ltd
SZSE:000963
65B CNY
15%
9%
18%
14%
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
7%
3%
9%
5%
CN
Sinopharm Group Co Ltd
HKEX:1099
65.4B HKD
12%
2%
15%
7%
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
60.9B CNY
6%
2%
9%
5%
IT
Amplifon SpA
MIL:AMP
5.5B EUR
14%
4%
11%
6%
Country CN
Market Cap 14.3B CNY
ROE
29%
ROA
13%
ROCE
29%
ROIC
20%
Country US
Market Cap 77.5B USD
ROE
-105%
ROA
4%
ROCE
27%
ROIC
18%
Country US
Market Cap 48.9B USD
ROE
258%
ROA
2%
ROCE
23%
ROIC
17%
Country US
Market Cap 48.7B USD
ROE
258%
ROA
2%
ROCE
23%
ROIC
17%
Country US
Market Cap 30.4B USD
ROE
-37%
ROA
3%
ROCE
26%
ROIC
17%
Country US
Market Cap 9.3B USD
ROE
9%
ROA
3%
ROCE
8%
ROIC
5%
Country CN
Market Cap 65B CNY
ROE
15%
ROA
9%
ROCE
18%
ROIC
14%
Country KR
Market Cap 12.2T KRW
ROE
7%
ROA
3%
ROCE
9%
ROIC
5%
Country CN
Market Cap 65.4B HKD
ROE
12%
ROA
2%
ROCE
15%
ROIC
7%
Country CN
Market Cap 60.9B CNY
ROE
6%
ROA
2%
ROCE
9%
ROIC
5%
Country IT
Market Cap 5.5B EUR
ROE
14%
ROA
4%
ROCE
11%
ROIC
6%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More
Back to Top